These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 7946802)

  • 1. Renoprotective role of ACE inhibitors in diabetic nephropathy.
    Mogensen CE
    Br Heart J; 1994 Sep; 72(3 Suppl):S38-45. PubMed ID: 7946802
    [No Abstract]   [Full Text] [Related]  

  • 2. [Renal histopathology of diabetic nephropathy].
    Suzuki Y
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():314-9. PubMed ID: 15999726
    [No Abstract]   [Full Text] [Related]  

  • 3. Should all diabetic patients take ACE inhibitors, even those without proteinuria?
    Hoogwerf BJ
    Cleve Clin J Med; 1999 Apr; 66(4):208-9. PubMed ID: 10199056
    [No Abstract]   [Full Text] [Related]  

  • 4. [Renoprotective effects of ACE inhibitors and AT1 antagonists on diabetic nephropathy beyond blood pressure control].
    Shionoiri H; Yasuda G; Takizawa T; Shionoiri F
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():394-9. PubMed ID: 15999741
    [No Abstract]   [Full Text] [Related]  

  • 5. Diabetes and ACE inhibitors.
    Boulton AJ; Gokal R
    J Hum Hypertens; 1990 Oct; 4 Suppl 4():63-6; discussion 66-7. PubMed ID: 2283656
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.
    Cooper ME
    J Hypertens Suppl; 1996 Dec; 14(6):S11-4. PubMed ID: 9023709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Should normotensive diabetic patients with microalbuminuria be treated with angiotensin converting enzyme inhibitors?].
    Feldt-Rasmussen BF
    Ugeskr Laeger; 2002 Apr; 164(14):1907-9. PubMed ID: 11957423
    [No Abstract]   [Full Text] [Related]  

  • 8. ACE inhibition in diabetic nephropathy.
    Parving HH
    J Diabet Complications; 1990; 4(2):86-7. PubMed ID: 2145310
    [No Abstract]   [Full Text] [Related]  

  • 9. Controversies on the prevention of diabetic nephropathy.
    Chiarelli F; Verrotti A; Basciani F; di Ricco L; Sabatino G; Morgese G
    J Pediatr Endocrinol Metab; 1998 Apr; 11 Suppl 2():365-9. PubMed ID: 9642666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic nephropathy: are we making progress in delaying renal failure?
    Barnes CC
    Clin Biochem; 1993 Aug; 26(4):318-9. PubMed ID: 8242896
    [No Abstract]   [Full Text] [Related]  

  • 11. Micro-albuminuria and the organ-damage concept in antihypertensive therapy for patients with insulin-dependent diabetes mellitus.
    Mogensen CE; Petersen MM; Hansen KW; Christensen CK
    J Hypertens Suppl; 1992 Apr; 10(1):S43-51. PubMed ID: 1619502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should Angiotensin converting enzyme inhibitors be used in children with type 1 diabetes and microalbuminuria?
    Almerie MQ; Williams RM; Acerini CL
    Arch Dis Child; 2008 Jul; 93(7):633-5. PubMed ID: 18285389
    [No Abstract]   [Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
    Hughes DB; Britton ML
    Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prediction, screening and treatment of renal complications of diabetes].
    Marre M; Larger E
    Rev Prat; 2001 Oct; 51(16):1769-75. PubMed ID: 11795120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
    Crook ED; Preddie DC
    Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ACE inhibition on the course of nephropathy in type I diabetes mellitus.
    Meinders AE; Hes R; de Leeuw PW
    Neth J Med; 1992 Jun; 40(5-6):217-20. PubMed ID: 1436257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating diabetic nephropathy--are there only economic issues?
    Mitch WE
    N Engl J Med; 2004 Nov; 351(19):1934-6. PubMed ID: 15516698
    [No Abstract]   [Full Text] [Related]  

  • 18. [Angiotensin-converting enzyme inhibitors in the treatment of diabetic nephropathy].
    Sawicki PT; Mühlhäuser I; Berger M
    Dtsch Med Wochenschr; 1994 Sep; 119(38):1298-9. PubMed ID: 7924925
    [No Abstract]   [Full Text] [Related]  

  • 19. [Can progression to terminal renal insufficiency be avoided in diabetic nephropathy?].
    Luño J; Valderrábano F
    An Med Interna; 1998 Nov; 15(11):567-71. PubMed ID: 9882851
    [No Abstract]   [Full Text] [Related]  

  • 20. ACE inhibitors and diabetic nephropathy.
    Molitch ME
    Diabetes Care; 1994 Jul; 17(7):756-60. PubMed ID: 7924789
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.